Hester Biosciences Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Hester Biosciences Limited generated cash of $481,340,000, which is more than the previous year. Cash used in financing activities reached the amount of -$260,450,000 last year. Net change in cash is therefore -$4,080,000.
Cash Flow
| 2010 | 136.33M | -34.57M | -98.68M |
|---|---|---|---|
| 2011 | 130.25M | -62.26M | -68.47M |
| 2012 | 141.61M | -102.14M | -18.39M |
| 2016 | 194.43M | -138.42M | -67.37M |
| 2018 | 380.24M | -258.29M | -110.78M |
| 2020 | 382.92M | -744.73M | 186.19M |
| 2021 | 580.53M | -383.72M | -182.19M |
| 2023 | 235.96M | -769.99M | 417.58M |
| 2024 | 481.34M | -226.54M | -260.45M |
HESTERBIO.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 131.56M | 247.5M | 235.31M | 406.47M | 111.80M | 61.22M | 15.92M | 9.57M | 6.50M |
Operating activities | |||||||||
Net income | 188.89M | 401.54M | 501.03M | 413.26M | 361.21M | 243.31M | 76.08M | 75.96M | 60.33M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 171.74M | 206.95M | 133.14M | 132.29M | 96.59M | 57.51M | 41.23M | 44.77M | 42.33M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 5.29M | -249.65M | 82.47M | -256.32M | -60.92M | -82.31M | 0 | 0 | 0 |
Inventories | 92.29M | -94.28M | 17.46M | -131.82M | -60.40M | -45.12M | -48.83M | -57.18M | -52.49M |
Accounts payable | -35.41M | 119.64M | 80.63M | 98.63M | 4.29M | 12.16M | 0 | 0 | 0 |
Cash generated by operating activities | 481.34M | 235.96M | 580.53M | 382.92M | 380.24M | 194.43M | 141.61M | 130.25M | 136.33M |
Investing activities | |||||||||
Purchases Of Investments | 0 | -2.53M | -420K | -23.29M | -3.05M | -682.94K | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -243.97M | -777.62M | -407.42M | -734.98M | -229.70M | -138.97M | -107.17M | -38.57M | -35.38M |
Acquisitions Net | 0 | 250K | 420K | 9.81M | -26.34M | 3.76M | 0 | -25M | 0 |
Cash generated by investing activities | -226.54M | -769.99M | -383.72M | -744.73M | -258.29M | -138.42M | -102.14M | -62.26M | -34.57M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 19.64M | 0 | 0 | 14.05M | 49.32M | 16.44M | 0 |
Payments for dividends | -68.05M | -85.07M | -56.15M | -71.79M | -64.50M | -51.89M | -18.17M | -14.79M | -12.97M |
Repurchases of common stock | 0 | 0 | 228.97M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -299.99M | 389.2M | -228.97M | 181.25M | -5.92M | 13.04M | 0 | -45.64M | -89.85M |
Cash used in financing activities | -260.45M | 417.58M | -182.19M | 186.19M | -110.78M | -67.37M | -18.39M | -68.47M | -98.68M |
Net Change In Cash | -4.08M | -115.94M | -22.62M | -175.61M | 11.47M | -11.36M | 21.07M | -483.72K | 3.06M |
Cash at end of period | 127.48M | 131.56M | 212.69M | 230.85M | 123.27M | 49.86M | 36.99M | 9.08M | 9.57M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |